NCT00321997View on ClinicalTrials.gov

A Clinical Trial to Explore Safety and Efficacy of Different Doses of Pegaptanib Sodium, Compared to Sham, in Patients With Wet AMD.

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

540

Participants

Timeline

Start Date

May 31, 2001

Study Completion Date

October 31, 2007

Conditions
Age-Related Macular Degeneration
Interventions
DRUG

Pegaptanib sodium

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Eyetech Pharmaceuticals

INDUSTRY